Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies

By Aslibekyan Stella   Straka Robert J   Irvin Marguerite R   Claas Steven A   Arnett Donna K  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 355-364

Informa Healthcare

Access to resources Recommend Favorite

Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome

By  

Current Vascular Pharmacology, Vol. 6, Iss. 4, 2008-10 ,pp. : 271-281

Bentham Science Publishers

Access to resources Recommend Favorite

The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese

By Ko Y.-L.   Hsu L.-A.   Hsu K.-H.   Ko Y.-H.   Lee Y.-S.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite

Serum Cholesterol Concentration and Prevalence, Awareness, Treatment, and Control of High Low‐Density Lipoprotein Cholesterol in the Korea National Health and Nutrition Examination Surveys 2008–2010: Beyond the Tip of the Iceberg

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phenotypes and Genotypes of High Density Lipoprotein Cholesterol in Exceptional Longevity

By  

Current Vascular Pharmacology, Vol. 12, Iss. 5, 2014-09 ,pp. : 690-697

Bentham Science Publishers

Access to resources Recommend Favorite